MedPath

Citalopram Hydrobromide

Citalopram Tablets, USP

Approved
Approval ID

c584909b-e7b2-7108-e053-2995a90a2f54

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jun 24, 2021

Manufacturers
FDA

NuCare Pharmaceuticals,Inc.

DUNS: 010632300

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Citalopram Hydrobromide

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68071-1830
Application NumberANDA078216
Product Classification
M
Marketing Category
C73584
G
Generic Name
Citalopram Hydrobromide
Product Specifications
Route of AdministrationORAL
Effective DateJune 24, 2021
FDA Product Classification

INGREDIENTS (1)

CITALOPRAM HYDROBROMIDEActive
Quantity: 20 mg in 1 1
Code: I1E9D14F36
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Citalopram Hydrobromide - FDA Drug Approval Details